Wednesday, September 23, 2026

USD/EUR Rises By 2% In The Last 21 Sessions

ViaNews Editorial Team

February 14, 2024

USD/EUR Rises By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.19% for the last 21 sessions. At 07:10 EST on Wednesday, 14 February, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 5.266% up from its 52-week low and 2.445% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.12%, a positive 0.09%, and a positive 0.32%, respectively.

USD/EUR's highest amplitude of average volatility was 0.12% (last week), 0.25% (last month), and 0.32% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 13 February, "Eren Sengezer, European Session Lead Analyst at FXStreet, offers a brief technical outlook for EUR/USD and explains: "EUR/USD holds steady at around 1.0800, where the 100-day Simple Moving Average (SMA) and the Fibonacci 50% retracement of the October-December uptrend align. "
  • Eur/usd: low for longer outlook – rabobank. According to FXStreet on Monday, 12 February, "This factor, combined with the potentially USD supportive factors identified above, underpins our view that EUR/USD is likely to be more comfortable in a 1.0400 to 1.1200 range over the next 24 months or so than at levels over 1.1500."
  • Eur/usd analysis: warning of oversold levels - 12 February 2024. According to DailyForex on Monday, 12 February, "According to the performance on the daily chart above, the general trend of the EUR/USD pair is still bearish, and as we mentioned before, moving below the psychological support level of 1.0800 will support the bears to move further downward. "
  • Eur/usd churns on Monday with pair hampered by technical barriers. According to FXStreet on Monday, 12 February, "The pair remains capped by the 200-hour Simple Moving Average (SMA), and Monday's test above 1.0800 saw the EUR/USD quickly rejected back into the 1.0770 region.", "The EUR/USD remains down over 3% from December's peak bids near 1.1150, and a bearish trend sees little topside potential for the pair as the 50-day SMA turns bearish and is set for a downside crossover of the 200-day SMA."
  • Eur/usd can find some support back above 1.0800 – ING. According to FXStreet on Monday, 12 February, "The holding pattern that EUR/USD has shown recently may well remain the norm in the coming weeks.", "We see some modest downside risks for the Dollar this week, and think EUR/USD can find some support back above 1.0800, although a return to the 1.0930/1.0950 area looks premature."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com